Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Galderma
Entity

Galderma

Tracked across 1 events · 7 articles · First seen Feb 27, 2026 · Last active Feb 28, 2026

Sentiment
75
Attention
4
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 75
Business
Galderma's Nemluvio Shows Long-Term Efficacy
Galderma announced positive long-term safety and efficacy data for Nemluvio in treating prurigo nodularis, which is expected to positively impact its stock and market position in dermatology. The company holds exclusive development and marketing rights for Nemluvio worldwide, except in Japan.
Feb 27, 2026 · 7 articles
Relationships (1)
Baldo Scassellati Sforzolini Global Head of R&D ↔ Galderma Baldo Scassellati Sforzolini is the Global Head of R&D at Galderma.
NEWSDESK
Track Galderma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.